Division of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan.
Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Kobe, Japan.
J Virol. 2020 Feb 28;94(6). doi: 10.1128/JVI.01851-19.
Human herpesvirus 6B (HHV-6B), a T-lymphotropic virus, infects almost exclusively humans. An animal model of HHV-6B has not been available. Here, we report the first animal model to mimic HHV-6B pathogenesis; the model is based on humanized mice in which human immune cells were engrafted and maintained. For HHV-6B replication, adequate human T-cell activation (which becomes susceptible to HHV-6B) is necessary in this murine model. Here, we found that an additional transfer of human mononuclear cells to humanized mice resulted in an explosive proliferation of human activated T cells, which could be representative of graft-versus-host disease (GVHD) because the primary transfer of human cells was not sufficient to increase the number and ratio of human T cells. Mice infected with HHV-6B became weak and/or died approximately 7 to 14 days later. Quantitative PCR analysis revealed that the spleen and lungs were the major sites of HHV-6B replication in this model, and this was corroborated by the detection of viral proteins in these organs. Histological analysis also revealed the presence of megakaryocytes, indicating HHV-6B infection. Multiplex analysis of cytokines/chemokines in sera from the infected mice showed secretions of human cytokines/chemokines as reported for both infection and clinical samples, indicating that the secreted cytokines could affect pathogenesis. This is the first animal model showing HHV-6B pathogenesis, and it will be useful for elucidating the pathogenicity of HHV-6B, which is related to GVHD and idiopathic pneumonia syndrome. Human herpesvirus 6B (HHV-6B) is a ubiquitous virus that establishes lifelong latent infection only in humans, and the infection can reactivate, with severe complications that cause major problems. A small-animal model of HHV-6B infection has thus been desired for research regarding the pathogenicity of HHV-6B and the development of antiviral agents. We generated humanized mice by transplantation with human hematopoietic stem cells, and here, we modified the model by providing an additional transfer of human mononuclear cells, providing the proper conditions for efficient HHV-6B infection. This is the first humanized mouse model to mimic HHV-6B pathogenesis, and it has great potential for research into the pathogenesis of HHV-6B.
人类疱疹病毒 6B(HHV-6B)是一种 T 淋巴细胞嗜性病毒,仅感染人类。目前还没有 HHV-6B 的动物模型。在这里,我们报告了第一个模拟 HHV-6B 发病机制的动物模型;该模型基于人源化小鼠,其中移植并维持了人类免疫细胞。对于 HHV-6B 的复制,在这种鼠模型中,需要足够的人类 T 细胞激活(这会使人类 T 细胞易感染 HHV-6B)。在这里,我们发现,将额外的人类单核细胞转移到人源化小鼠中会导致人类活化 T 细胞的爆炸性增殖,这可能代表移植物抗宿主病(GVHD),因为初次转移的人类细胞不足以增加人类 T 细胞的数量和比例。感染 HHV-6B 的小鼠大约在 7 至 14 天后变得虚弱和/或死亡。定量 PCR 分析显示,脾脏和肺部是该模型中 HHV-6B 复制的主要部位,并且在这些器官中检测到病毒蛋白证实了这一点。组织学分析还显示巨核细胞的存在,表明存在 HHV-6B 感染。从感染小鼠的血清中细胞因子/趋化因子的多重分析显示,正如感染和临床样本所报道的那样,人类细胞因子/趋化因子的分泌表明分泌的细胞因子可能会影响发病机制。这是第一个显示 HHV-6B 发病机制的动物模型,它将有助于阐明与 GVHD 和特发性肺炎综合征相关的 HHV-6B 的致病性。人类疱疹病毒 6B(HHV-6B)是一种普遍存在的病毒,仅在人类中建立终身潜伏感染,并且感染会重新激活,导致严重的并发症,造成重大问题。因此,人们一直希望建立一种用于研究 HHV-6B 致病性和开发抗病毒药物的 HHV-6B 感染的小动物模型。我们通过移植人类造血干细胞生成了人源化小鼠,在这里,我们通过提供额外的人类单核细胞转移来修饰模型,为有效 HHV-6B 感染提供了适当的条件。这是第一个模拟 HHV-6B 发病机制的人源化小鼠模型,对于研究 HHV-6B 的发病机制具有很大的潜力。